Inventiva (IVA) Total Liabilities (2018 - 2025)
Inventiva (IVA) recorded quarterly Total Liabilities of $323.6 million in Q4 2025, down 99.85% quarter-over-quarter from $212.7 billion in Q2 2025, and up 34.24% on a YoY basis from $241.1 million in Q4 2024.
Inventiva (IVA) Total Liabilities (2018 - 2025) Analysis & Trends
Inventiva's Total Liabilities history runs 8 years deep, the most recent figure standing at $323.6 million for Q4 2025.
- In Q4 2025, Total Liabilities rose 34.24% year-over-year to $323.6 million; the TTM figure through Dec 2025 stood at $323.6 million (up 34.24% YoY), while the FY2025 annual figure was $323.6 million, up 34.24% from the prior year.
- Total Liabilities was $323.6 million for Q4 2025 at Inventiva, down from $212.7 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $212.7 billion in Q2 2025 to a low of -$74.4 billion in Q2 2022.
- Historically, Total Liabilities has averaged $12.6 billion across 5 years, with a median of $37.9 million in 2021.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities plunged 215421.53% in 2022, then surged 1039322947.88% in 2025.
- A 5-year view of Total Liabilities shows it stood at $37.9 million in 2021, then jumped by 89.92% to $72.0 million in 2022, then soared by 51.91% to $109.3 million in 2023, then jumped by 120.56% to $241.1 million in 2024, then jumped by 34.24% to $323.6 million in 2025.
- The last three Total Liabilities figures came in at $323.6 million (Q4 2025), $212.7 billion (Q2 2025), and $241.1 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 137.56 Mn |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | 323.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 323.64 Mn |
| Jun 30, 2025 | 212.65 Bn |
| Dec 31, 2024 | 241.09 Mn |
| Jun 30, 2024 | 20,460.86 |
| Dec 31, 2023 | 109.31 Mn |
| Oct 11, 2023 | 10.40 Mn |
| Dec 31, 2022 | 71.96 Mn |
| Jun 30, 2022 | -74.40 Bn |
| Dec 31, 2021 | 37.89 Mn |
| Jun 30, 2021 | 34.55 Mn |
| Mar 31, 2021 | 27.04 Mn |
| Dec 31, 2020 | 33.04 Mn |
| Jun 30, 2020 | 29.73 Mn |
| Dec 31, 2019 | 17.23 Mn |
| Dec 31, 2018 | 20.79 Mn |